Dr. Michael Method, M.D

NPI: 1437153913
Total Payments
$121,916
2024 Payments
$73.29
Companies
17
Transactions
149

Payment Breakdown by Category

Other$86,000 (70.5%)
Travel$28,391 (23.3%)
Food & Beverage$3,815 (3.1%)
Consulting$3,700 (3.0%)
Education$9.91 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $86,000 23 70.5%
Travel and Lodging $28,391 56 23.3%
Food and Beverage $3,815 66 3.1%
Consulting Fee $3,700 3 3.0%
Education $9.91 1 0.0%

Top Paying Companies

Company Total Records Latest Year
Clovis Oncology, Inc. $84,711 68 $0 (2018)
TESARO, Inc. $34,002 40 $0 (2018)
GlaxoSmithKline, LLC. $1,412 5 $0 (2024)
Intuitive Surgical, Inc. $1,257 21 $0 (2018)
Stryker Corporation $109.63 1 $0 (2017)
AstraZeneca Pharmaceuticals LP $91.05 2 $0 (2022)
Novo Nordisk Inc $89.26 1 $0 (2019)
Puma Biotechnology, Inc. $45.00 1 $0 (2018)
Lilly USA, LLC $37.15 1 $0 (2018)
Eisai Inc. $36.00 1 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $73.29 2 GlaxoSmithKline, LLC. ($42.66)
2023 $36.00 1 Eisai Inc. ($36.00)
2022 $128.28 3 AstraZeneca Pharmaceuticals LP ($91.05)
2020 $1,332 3 GlaxoSmithKline, LLC. ($1,332)
2019 $89.26 1 Novo Nordisk Inc ($89.26)
2018 $51,266 58 Clovis Oncology, Inc. ($44,964)
2017 $68,991 81 Clovis Oncology, Inc. ($39,746)

All Payment Transactions

149 individual payment records from CMS Open Payments — Page 1 of 6

Date Company Product Nature Form Amount Type
04/03/2024 GENZYME CORPORATION FABRAZYME (Biological) Food and Beverage In-kind items and services $30.63 General
Category: Genetic Disease
03/17/2024 GlaxoSmithKline, LLC. Food and Beverage In-kind items and services $42.66 General
03/25/2023 Eisai Inc. Lenvima (Drug) Food and Beverage Cash or cash equivalent $36.00 General
Category: Oncology
09/30/2022 AstraZeneca Pharmaceuticals LP LYNPARZA (Drug) Food and Beverage In-kind items and services $44.68 General
Category: Oncology
09/29/2022 GlaxoSmithKline, LLC. Food and Beverage In-kind items and services $37.23 General
03/21/2022 AstraZeneca Pharmaceuticals LP LYNPARZA (Drug) Food and Beverage In-kind items and services $46.37 General
Category: Oncology
02/13/2020 GlaxoSmithKline, LLC. Travel and Lodging In-kind items and services $894.80 General
02/13/2020 GlaxoSmithKline, LLC. Travel and Lodging In-kind items and services $265.61 General
02/13/2020 GlaxoSmithKline, LLC. Travel and Lodging In-kind items and services $171.60 General
06/20/2019 Novo Nordisk Inc Saxenda (Drug) Food and Beverage In-kind items and services $89.26 General
Category: Obesity
10/12/2018 Puma Biotechnology, Inc. Nerlynx (Drug) Food and Beverage In-kind items and services $45.00 General
Category: Oncology
10/01/2018 Clovis Oncology, Inc. Rubraca (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $4,000.00 General
Category: Oncology
09/27/2018 Clovis Oncology, Inc. Rubraca (Drug) Travel and Lodging In-kind items and services $736.23 General
Category: Oncology
09/27/2018 Clovis Oncology, Inc. Rubraca (Drug) Travel and Lodging In-kind items and services $646.60 General
Category: Oncology
09/27/2018 Clovis Oncology, Inc. Rubraca (Drug) Travel and Lodging In-kind items and services $175.56 General
Category: Oncology
09/27/2018 Clovis Oncology, Inc. Rubraca (Drug) Food and Beverage In-kind items and services $125.00 General
Category: Oncology
09/17/2018 Clovis Oncology, Inc. Rubraca (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,500.00 General
Category: Oncology
09/13/2018 Clovis Oncology, Inc. Rubraca (Drug) Travel and Lodging In-kind items and services $546.63 General
Category: Oncology
09/13/2018 Clovis Oncology, Inc. Rubraca (Drug) Food and Beverage In-kind items and services $124.20 General
Category: Oncology
08/08/2018 Clovis Oncology, Inc. Rubraca (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $4,000.00 General
Category: Oncology
08/03/2018 Clovis Oncology, Inc. Rubraca (Drug) Travel and Lodging In-kind items and services $321.27 General
Category: Oncology
08/02/2018 Clovis Oncology, Inc. Rubraca (Drug) Travel and Lodging In-kind items and services $866.60 General
Category: Oncology
08/02/2018 Clovis Oncology, Inc. Rubraca (Drug) Travel and Lodging In-kind items and services $596.64 General
Category: Oncology
08/02/2018 Clovis Oncology, Inc. Rubraca (Drug) Travel and Lodging In-kind items and services $196.62 General
Category: Oncology
08/02/2018 Clovis Oncology, Inc. Rubraca (Drug) Food and Beverage In-kind items and services $125.00 General
Category: Oncology

About Dr. Michael Method, M.D

Dr. Michael Method, M.D is a Gynecologic Oncology healthcare provider based in Indianapolis, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/13/2005. The National Provider Identifier (NPI) number assigned to this provider is 1437153913.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Method, M.D has received a total of $121,916 in payments from pharmaceutical and medical device companies, with $73.29 received in 2024. These payments were reported across 149 transactions from 17 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($86,000).

Practice Information

  • Specialty Gynecologic Oncology
  • Other Specialties Gynecologic Oncology
  • Location Indianapolis, IN
  • Active Since 06/13/2005
  • Last Updated 05/03/2017
  • Taxonomy Code 207VX0201X
  • Entity Type Individual
  • NPI Number 1437153913

Products in Payments

  • Rubraca (Drug) $84,711
  • ZEJULA (Drug) $34,002
  • Da Vinci Surgical System (Device) $1,257
  • vitagel (Device) $109.63
  • LYNPARZA (Drug) $91.05
  • Saxenda (Drug) $89.26
  • Nerlynx (Drug) $45.00
  • CYRAMZA (Drug) $37.15
  • Lenvima (Drug) $36.00
  • FABRAZYME (Biological) $30.63
  • YONDELIS (Drug) $20.53
  • KEYTRUDA (Biological) $19.40
  • Avastin (Biological) $14.59
  • ENSEAL Product Family (Device) $14.16
  • EXPAREL (Drug) $12.37
  • ZYTIGA (Drug) $10.84

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Gynecologic Oncology Doctors in Indianapolis